Chargement en cours...
Liraglutide 3.0 mg for Weight Management: A Population Pharmacokinetic Analysis
BACKGROUND AND OBJECTIVES: This analysis used a population pharmacokinetic approach to identify covariates that influence plasma exposure of liraglutide 3.0 mg, a glucagon-like peptide-1 (GLP-1) receptor agonist approved for weight management in overweight and obese individuals. METHODS: Samples for...
Enregistré dans:
| Publié dans: | Clin Pharmacokinet |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer International Publishing
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5069304/ https://ncbi.nlm.nih.gov/pubmed/27193270 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40262-016-0410-7 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|